Oral tolerance in myasthenia gravis

Annals of the New York Academy of Sciences

Volumn 778, Issue , 1996, Pages 258-272

  Drachman, Daniel B ^a   Okumura, Seiichi ^a,b   Adams, Robert N ^a   McIntosh, Kevin R ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b KANAZAWA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINERGIC RECEPTOR; FREUND ADJUVANT; INTERLEUKIN 2; OVALBUMIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY PRODUCTION; ANTIGEN PURIFICATION; ARTICLE; AUTOIMMUNITY; CELL PROLIFERATION; CONTROLLED STUDY; IMMUNIZATION; IMMUNOLOGICAL TOLERANCE; LYMPH NODE CELL; MYASTHENIA GRAVIS; NONHUMAN; RAT;

EID: 0029962865     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1996.tb21134.x     Document Type: Article

References (58)

1. OKUMURA, S., K. MCINTOSH & D. B. DRACHMAN. 1994. Oral administration of acetylcholine receptor: Effects on experimental myasthenia gravis. Ann. Neurol. 36: 704-713.
2. WANG, Z-Y., J. QIAO & H. LINK. 1993. Suppression of experimental autoimmune myasthenia gravis by oral administration of acetylcholine receptor. J. Neuroimmunol. 44: 209-214.
3. DRACHMAN, D. B. 1994. Myasthenia gravis. Medical Progress. N. Engl. J. Med. 330: 1797-1810.
4. GROB, D., E. L. ARSURA, N. G. BRUNNER & T. NAMBA. 1987. The course of myasthenia gravis and therapies affecting outcome. Ann. N.Y. Acad. Sci. 505: 472-499.
5. GROB, D., N. G. BRUNNER & T. NAMBA. 1981. The natural course of myasthenia gravis and effect of therapeutic measures. Ann. N.Y. Acad. Sci. 377: 652-669.
6. FAMBROUGH, D. M., D. B. DRACHMAN & S. SATYAMURTI. 1973. Neuromuscular junction in myasthenia gravis: Decreased acetylcholine receptors. Science 182: 293-5.
7. PESTRONK, A., D. B. DRACHMAN & S. SELF. 1985. Measurement of junctional acetylcholine receptors in myasthenia gravis: Clinical correlates. Muscle & Nerve 8: 245-51.
8. CHANGEUX, J. P. 1990. Functional architecture and dynamics of the nicotinic acetylcholine receptor: An allosteric ligand-gated ion channel. In Fidia Research Foundation Neuroscience Award Lectures. 4: 21-168. Raven. New York.
9. NODA, M., Y. FURUTANI, H. TAKAHASHI et al. 1983. Cloning and sequence analysis of calf cDNA and human genomic DNA encoding α-subunit precursor of muscle acetylcholine receptor. Nature 305: 818-823.
10. BEESON, D., M. BRYDWON, H. WOOD, A. VINCENT & J. NEWSOM-DAVIS. 1989. Human muscle acetylcholine receptor: Cloning and expression in Escherichia coli of cDNA for the alpha-subunit. Biochem. Soc. Trans. 17: 219-20.
11. COHEN, J. B. & J-P. CHANGEUX. 1975. The cholinergic receptor protein in its membrane environment. Annu. Rev. Pharmacol. 15: 83-103.
12. UNWIN, N. 1995. Acetylcholine receptor channel imaged in the open state. Nature 373: 37-43.
13. TALIB, S., K. R. LEIBY & T. B. OKARMA. 1991. Cloning and expression in Escherichia coli of a synthetic gene encoding the extracellular domain of the human muscle acetylcholine receptor alpha-subunit. Gene 98: 289-93.
14. MISHINA, M., T. KUROSAKI, T. TOBIMATSU et al. 1984. Expression of functional acetylcholine receptor from cloned cDNAS. Nature 307: 604-608.
15. PATRICK, J. & J. LINDSTROM. 1973. Autoimmune response to acetylcholine receptor. Science 180: 871-72.
16. ENGEL, A. G., M. T. TSUJIHATA, E. H. LAMBERT, J. M. LINDSTROM & V. A. LENNON. 1976. Experimental autoimmune myasthenia gravis: A sequential and quantitative study of the neuromuscular junction ultrastructure and electrophysiologic correlation. J. Neuropathol. Exp. Neurol. 35: 569-587.
17. PENN, A. S., H. W. CHANG, R. E. LOVELACE, W. NIEMI & A. MIRANDA. 1976. Antibodies to acetylcholine receptors in rabbits: Immunological and electrophysiological studies. Ann. N.Y. Acad. Sci. 274: 354-76.
18. DRACHMAN, D. B., K. R. MCINTOSH, J. REIM & L. BALCER. 1993. Strategies for treatment of myasthenia gravis. Ann. N.Y. Acad. Sci. 681: 515-528.
19. TOYKA, K. V., D. B. DRACHMAN, D. E. GRIFFIN et al. 1977. Myasthenia gravis: Study of humoral immune mechanisms by passive transfer to mice. N. Engl. J. Med. 296: 125-31.
20. PINCHING, A. J., D. K. PETERS & J. N. NEWSOM-DAVIS. 1976. Remission of myasthenia gravis following plasma exchange. Lancet 2: 1373-1376.
21. KEESEY, J., D. BUFFKIN, D. KEBO, W. HO & C. HERRMANN JR. 1981. Plasma exchange alone as therapy for myasthenia gravis. Ann. N.Y. Acad. Sci. 377:729-743.
22. DAU, P. C., J. M. LINDSTROM, C. K. CASSEL, E. H. DENYS, E. E. SHEV & L. E. SPITLER. 1977. Plasmapheresis and immunosuppressive drug therapy in myasthenia gravis. N. Engl. J. Med. 297: 1134-1140.
23. KAO, I. & D. B. DRACHMAN. 1977. Myasthenic immunoglobulin accelerates acetylcholine receptor degradation. Science 196: 527-9.
24. DRACHMAN, D. B., R. N. ADAMS, L. F. JOSIFEK & S. G. SELF. 1982. Functional activities of autoantibodies to acetylcholine receptors and the clinical severity of myasthenia gravis. N. Engl. J. Med. 307: 769-75.
25. ENGEL, A. G. & K. ARAHATA. 1987. The membrane attack complex of complement at the endplate in myasthenia gravis. Ann. N.Y. Acad. Sci. 505: 326-32.
26. DRACHMAN, D. B. 1992. Myasthenia gravis. In Current Therapy in Neurologic Disease. R. Johnson & J. W. Griffin, Eds. B. C. Decker. St. Louis.
27. JOHNS, T. R. 1987. Long-term corticosteroid treatment of myasthenia gravis. Ann. N.Y. Acad. Sci. 505: 568-583.
28. MICHELS, M., R. HOHLFELD, H-P. HARTUNG, K. HEININGER, U. A. BESINGER & K. V. TOYKA. 1988. Myasthenia gravis: discontinuation of long-term azathioprine. Ann. Neurol. 24: 798.
29. NOSSAL, G. J. V. 1987. Possible strategies for the treatment of myasthenia gravis and other autoimmune diseases. Ann. N.Y. Acad. Sci. 505: 610-618.
30. DRACHMAN, D. B. & R. W. KUNCL. 1994. Myasthenia gravis. In Immunology of Neuromuscular Diseases. R. Hohlfeld, Eds.: Chapter 7: 165-207. Kluwer Academic Publishers. Dordrecht, Boston, London.
31. HIGGINS, P. J. & H. L. WEINER. 1988. Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein and its fragments. J. Immunol. 140: 440-445.
32. BITAR, D. M. & C. C. WHITACRE. 1988. Suppression of experimental autoimmune encephalomyelitis by the oral administration of myelin basic protein. Cell. Immunol. 112: 364-370.
33. NUSSENBLATT, R. B., R. P. CASPI, R. MAHDI et al. 1990. Inhibition of S-antigen induced experimental autoimmune uveoretinitis by oral induction of tolerance with S-antigen. J. Immunol. 144: 1689-1695.
34. SINGH, V. K., H. K. KALRA, K. YAMAKI & T. SHINOHARA. 1992. Suppression of experimental autoimmune uveitis in rats by the oral administration of the uveitopathogenic S-antigen fragment or a cross-reactive homologous peptide. Cell. Immunol. 139: 81-90.
35. NAGLER-ANDERSON, C., L. A. BOBER, M. E. ROBINSON et al. 1986. Suppression of type II collagen-induced arthritis by intragastric administration of soluble type II collagen. Proc. Natl. Acad. Sci. USA 83: 7443-7446.
36. THOMPSON, H. S. G. & N. A. STAINES. 1989. Suppression of collagen-induced arthritis with pergastrically or intravenously administered type II collagen. Agents Actions 19: 318-319.
37. WEINER, H. L., A. FRIEDMAN, A. MILLER et al. 1994. Oral tolerance: Immunologic mechanisms and treatment of animal and human organ-specific autoimmunity diseases by oral administration of autoantigens. Annu. Rev. Immunol. 12: 809-837.
38. WEKER, H. C., G. A. MACKIN, M. MATSUI et al. 1993. Double-blind pilot trial of ral tolerization with myelin antigens in multiple sclerosis. Science 259: 1321-1324.
39. TRENTHAM, D. E., A. DYNESIUM-TRENTHAM, E. J. ORAV et al. 1993. Effects of oral administration of type II collagen on rheumatoid arthritis. Science 261: 1727-1730.
40. HUSBY, S., J. MESTECKY, Z. MALDOVEANU, S. HOLLAND & C. O. ELSON. 1994. Oral tolerance in humans. J. Immunol. 152: 4663-4670.
41. BRAY, J. J. & D. B. DRACHMAN. 1982. Binding affinities of anti-acetylcholine receptor autoantibodies in myasthenia gravis. J. Immunol. 128: 105-110.
42. LENNON, V. A., J. M. LINSTROM & M. E. SEYBOLD. 1975. Experimental autoimmune myasthenia: A model of myasthenia gravis in rats and guinea pigs. J. Exp. Med. 141: 1365-1375.
43. RICHMAN, L. K., J. M. CHILLER, W. R. BROWN et al. 1978. Enterically induced immunological tolerance. I. Induction of suppressor lymphocytes by intragastric administration of soluble proteins. J. Immunol. 121: 2429-2434.
44. MATTTNGLY, J. & B. WAKSMAN. 1978. Immunologic suppression after oral administration of antigen. I. Specific suppressor cells found in rat Peyer's patches after oral administration of sheep erythrocytes, and their systemic migration. J. Immunol. 121: 1878-1883.
45. LIDER, O., L. M. B. SANTOS & C. S. Y. LEE. 1989. Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein. J. Immunol. 142: 748-752.
46. FRIEDMAN, A. & H. L. WEINER. 1994. Induction of anergy or active suppression following oral tolerance is determined by antigen dosage. Proc. Natl. Acad. Sci. USA 91: 6688-6692.
47. MCINTOSH, K. R., D. B. DRACHMAN & R. W. KUNCL. 1989. Antigen-specific suppressor macrophages induced by culture with cyclolporin A plus acetylcholine receptor. J. Neuroimmunol. 25: 75-89.
48. WANG, Z-Y., H. LINK, A. LJUNGDAHL et al. 1994. Induction of interferon γ, interleukin 4 and transforming growth factor-β in rats orally tolerized against experimental autoimmune myasthenia gravis. Cell. Immunol. 157: 353-368.
49. HEPPEL, L. M. J. & P. J. KILSHAW. 1982. Immune responses of guinea pigs to dietary protein. Int. Arch. Allergy. Appl. Immunol. 68: 54-59.
50. GAUTAM, S. C., N. F. CHIKKALA & J. R. BATTISTO. 1990. Oral administration of the contact sensitizer trinitrochlorobenzene: Initial sensitization and subsequent appearance of a suppressor population. Cell. Immunol. 125: 437-448.
51. STOKES, C. R., T. J. NEWBY & F. J. BOURNE. 1983. The influence of oral immunization on local and systemic immune responses to heterologous antigens. Clin. Exp. Immunol. 52: 399-406.
52. MOWAT, A. MCI. 1987. The regulation of immune responses to dietary protein antigens. Immunol. Today 8: 93-98.
53. WEINER, H. L. 1994. Oral tolerance. Proc. Natl. Acad. Sci. USA 91: 10762-10765.
54. LENNON, V. A., J. M. LINDSTROM & M. E. SEYBOLD. 1976. Experimental autoimmune myasthenia gravis: Cellular and humoral immune responses. Ann. N. Y. Acad. Sci. 274: 283-299.
55. HOHLFELD, R., K. V. TOYKA, M. MICHELS, K. HEININGER, B. CONTI-TRONCONI & S. J. TZARTOS. 1987. Acetylcholine receptor-specific human T-lymphocyte lines. Ann. N.Y. Acad. Sci. 505: 27-38.
56. TITUS, R. G. & J. M. CHILLER. 1981. Orally induced tolerance. Int. Arch Allergy Appl. Immunol. 65: 323-338.
57. HANSON, D. G., N. M. VAZ, D. A. RAWLINGS et al. 1979. Inhibition of specific immune responses by feeding protein antigens. II. Effects of prior passive and active immunization. J. Immunol. 122: 2261-2266.
58. LENS, J. W., B. VAN DEN BERG, L. B. A. VAN DI PUTTE & L. VEN DEN BERSSELAAR. 1984. Flare-up of antigen-induced arthritis in mice after challenge with oral antigen. Clin. Exp. Immunol. 58: 364-371.